rs377291339

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015922.3(NSDHL):​c.790-5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000299 in 1,203,895 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000032 ( 0 hom. 11 hem. )

Consequence

NSDHL
NM_015922.3 splice_region, intron

Scores

2
Splicing: ADA: 0.000008682
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.128

Publications

0 publications found
Variant links:
Genes affected
NSDHL (HGNC:13398): (NAD(P) dependent steroid dehydrogenase-like) The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
NSDHL Gene-Disease associations (from GenCC):
  • CHILD syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • CK syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-152868779-G-A is Benign according to our data. Variant chrX-152868779-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 159455.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000321 (35/1091891) while in subpopulation NFE AF = 0.000037 (31/837911). AF 95% confidence interval is 0.0000265. There are 0 homozygotes in GnomAdExome4. There are 11 alleles in the male GnomAdExome4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSDHLNM_015922.3 linkc.790-5G>A splice_region_variant, intron_variant Intron 7 of 7 ENST00000370274.8 NP_057006.1 Q15738A0A384NPZ7
NSDHLNM_001129765.2 linkc.790-5G>A splice_region_variant, intron_variant Intron 8 of 8 NP_001123237.1 Q15738A0A384NPZ7
NSDHLNM_001441099.1 linkc.790-5G>A splice_region_variant, intron_variant Intron 9 of 9 NP_001428028.1
NSDHLXM_017029564.2 linkc.838-5G>A splice_region_variant, intron_variant Intron 7 of 7 XP_016885053.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSDHLENST00000370274.8 linkc.790-5G>A splice_region_variant, intron_variant Intron 7 of 7 1 NM_015922.3 ENSP00000359297.3 Q15738
NSDHLENST00000440023.5 linkc.790-5G>A splice_region_variant, intron_variant Intron 8 of 8 5 ENSP00000391854.1 Q15738

Frequencies

GnomAD3 genomes
AF:
0.00000893
AC:
1
AN:
112004
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000278
AC:
5
AN:
179690
AF XY:
0.0000306
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000498
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000321
AC:
35
AN:
1091891
Hom.:
0
Cov.:
29
AF XY:
0.0000307
AC XY:
11
AN XY:
358203
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26322
American (AMR)
AF:
0.0000284
AC:
1
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19354
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30190
South Asian (SAS)
AF:
0.0000370
AC:
2
AN:
54060
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38798
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4124
European-Non Finnish (NFE)
AF:
0.0000370
AC:
31
AN:
837911
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000893
AC:
1
AN:
112004
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34178
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30754
American (AMR)
AF:
0.00
AC:
0
AN:
10623
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.000281
AC:
1
AN:
3561
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2719
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6110
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53165
Other (OTH)
AF:
0.00
AC:
0
AN:
1499
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264
EpiCase
AF:
0.00
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 30, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 30, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
Nov 14, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.029
DANN
Benign
0.38
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000087
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377291339; hg19: chrX-152037323; API